Literature DB >> 26784009

The effect of surface modification of mesoporous silica micro-rod scaffold on immune cell activation and infiltration.

Weiwei Aileen Li1, Beverly Ying Lu1, Luo Gu1, Youngjin Choi2, Jaeyun Kim2, David J Mooney3.   

Abstract

Biomaterial scaffold based vaccines show significant potential in generating potent antigen-specific immunity. However, the role of the scaffold surface chemistry in initiating and modulating the immune response is not well understood. In this study, a mesoporous silica micro-rod (MSR) scaffold was modified with PEG, PEG-RGD and PEG-RDG groups. PEG modification significantly enhanced BMDC activation marker up-regulation and IL-1β production in vitro, and innate immune cell infiltration in vivo. PEG-RGD MSRs and PEG-RDG MSRs displayed decreased inflammation compared to PEG MSRs, and the effect was not RGD specific. Finally, the Nlrp3 inflammasome was found to be necessary for MSR stimulated IL-1β production in vitro and played a key role in regulating immune cell infiltration in vivo. These findings suggest that simply modulating the surface chemistry of a scaffold can regulate its immune cell infiltration profile and have implications for the design and development of new material based vaccines.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute inflammation; Inflammasome; Mesoporous silica; Poly(ethylene glycol); RGD

Mesh:

Substances:

Year:  2016        PMID: 26784009      PMCID: PMC4754159          DOI: 10.1016/j.biomaterials.2016.01.026

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  53 in total

1.  Exploiting lymphatic transport and complement activation in nanoparticle vaccines.

Authors:  Sai T Reddy; André J van der Vlies; Eleonora Simeoni; Veronique Angeli; Gwendalyn J Randolph; Conlin P O'Neil; Leslie K Lee; Melody A Swartz; Jeffrey A Hubbell
Journal:  Nat Biotechnol       Date:  2007-09-16       Impact factor: 54.908

2.  Complement activation cascade triggered by PEG-PL engineered nanomedicines and carbon nanotubes: the challenges ahead.

Authors:  S M Moghimi; A J Andersen; S H Hashemi; B Lettiero; D Ahmadvand; A C Hunter; T L Andresen; I Hamad; J Szebeni
Journal:  J Control Release       Date:  2010-04-11       Impact factor: 9.776

3.  Complement activation by PEO-grafted glass surfaces.

Authors:  A Kidane; K Park
Journal:  J Biomed Mater Res       Date:  1999

4.  Zwitterionic gel encapsulation promotes protein stability, enhances pharmacokinetics, and reduces immunogenicity.

Authors:  Peng Zhang; Fang Sun; Caroline Tsao; Sijun Liu; Priyesh Jain; Andrew Sinclair; Hsiang-Chieh Hung; Tao Bai; Kan Wu; Shaoyi Jiang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-14       Impact factor: 11.205

5.  RGD-grafted poly-L-lysine-graft-(polyethylene glycol) copolymers block non-specific protein adsorption while promoting cell adhesion.

Authors:  Stephanie VandeVondele; Janos Vörös; Jeffrey A Hubbell
Journal:  Biotechnol Bioeng       Date:  2003-06-30       Impact factor: 4.530

6.  Differential expression of NLRP3 among hematopoietic cells.

Authors:  Greta Guarda; Manuel Zenger; Amir S Yazdi; Kate Schroder; Isabel Ferrero; Philippe Menu; Aubry Tardivel; Chantal Mattmann; Jürg Tschopp
Journal:  J Immunol       Date:  2011-01-21       Impact factor: 5.422

7.  In vitro degradation behavior of silica nanoparticles under physiological conditions.

Authors:  Nanjing Hao; Huiyu Liu; Linlin Li; Dong Chen; Laifeng Li; Fangqiong Tang
Journal:  J Nanosci Nanotechnol       Date:  2012-08

8.  Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth.

Authors:  Mélanie Bruchard; Grégoire Mignot; Valentin Derangère; Fanny Chalmin; Angélique Chevriaux; Frédérique Végran; Wilfrid Boireau; Benoit Simon; Bernhard Ryffel; Jean Louis Connat; Jean Kanellopoulos; François Martin; Cédric Rébé; Lionel Apetoh; François Ghiringhelli
Journal:  Nat Med       Date:  2012-12-02       Impact factor: 53.440

9.  Immunocompatibility properties of lipid-polymer hybrid nanoparticles with heterogeneous surface functional groups.

Authors:  Carolina Salvador-Morales; Liangfang Zhang; Robert Langer; Omid C Farokhzad
Journal:  Biomaterials       Date:  2009-01-23       Impact factor: 12.479

10.  MyD88-dependent expansion of an immature GR-1(+)CD11b(+) population induces T cell suppression and Th2 polarization in sepsis.

Authors:  Matthew J Delano; Philip O Scumpia; Jason S Weinstein; Dominique Coco; Srinivas Nagaraj; Kindra M Kelly-Scumpia; Kerri A O'Malley; James L Wynn; Svetlana Antonenko; Samer Z Al-Quran; Ryan Swan; Chun-Shiang Chung; Mark A Atkinson; Reuben Ramphal; Dmitry I Gabrilovich; Wesley H Reeves; Alfred Ayala; Joseph Phillips; Drake Laface; Paul G Heyworth; Michael Clare-Salzler; Lyle L Moldawer
Journal:  J Exp Med       Date:  2007-06-04       Impact factor: 14.307

View more
  24 in total

Review 1.  Biomaterials for vaccine-based cancer immunotherapy.

Authors:  Rui Zhang; Margaret M Billingsley; Michael J Mitchell
Journal:  J Control Release       Date:  2018-10-09       Impact factor: 9.776

Review 2.  Advances in immunotherapy delivery from implantable and injectable biomaterials.

Authors:  David G Leach; Simon Young; Jeffrey D Hartgerink
Journal:  Acta Biomater       Date:  2019-02-13       Impact factor: 8.947

3.  Precision-porous templated scaffolds of varying pore size drive dendritic cell activation.

Authors:  Ruying Chen; Hongyan Ma; Lei Zhang; James D Bryers
Journal:  Biotechnol Bioeng       Date:  2018-01-22       Impact factor: 4.530

4.  Anti-tumor immunity induced by ectopic expression of viral antigens is transient and limited by immune escape.

Authors:  Neeraja Dharmaraj; Stacey L Piotrowski; Chen Huang; Jared M Newton; Leonard S Golfman; Aurelie Hanoteau; Sandeep T Koshy; Aileen W Li; Merlyn X Pulikkathara; Bing Zhang; Jared K Burks; David J Mooney; Yu L Lei; Andrew G Sikora; Simon Young
Journal:  Oncoimmunology       Date:  2019-02-06       Impact factor: 8.110

Review 5.  Opportunities for Nitric Oxide in Potentiating Cancer Immunotherapy.

Authors:  Jihoon Kim; Susan N Thomas
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

6.  Versatile activity and morphological effects of zinc oxide submicron particles as anticancer agents.

Authors:  Junnan Geng; Gregory Jensen; Kyle Jackson; Jefferson Pontsler; Venkatakrishnan Rengarajan; Yan Sun; David Britt; Yu Huang
Journal:  Nanomedicine (Lond)       Date:  2022-03-30       Impact factor: 6.096

Review 7.  Immunostimulatory biomaterials to boost tumor immunogenicity.

Authors:  Oluwaseyi T Shofolawe-Bakare; Larry D Stokes; Mehjabeen Hossain; Adam E Smith; Thomas A Werfel
Journal:  Biomater Sci       Date:  2020-09-02       Impact factor: 6.843

Review 8.  Translational Applications of Hydrogels.

Authors:  Santiago Correa; Abigail K Grosskopf; Hector Lopez Hernandez; Doreen Chan; Anthony C Yu; Lyndsay M Stapleton; Eric A Appel
Journal:  Chem Rev       Date:  2021-05-03       Impact factor: 60.622

Review 9.  Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapy.

Authors:  Ariel Isser; Natalie K Livingston; Jonathan P Schneck
Journal:  Biomaterials       Date:  2020-12-05       Impact factor: 15.304

Review 10.  Hitchhiking on Controlled-Release Drug Delivery Systems: Opportunities and Challenges for Cancer Vaccines.

Authors:  Lu Han; Ke Peng; Li-Ying Qiu; Meng Li; Jing-Hua Ruan; Li-Li He; Zhi-Xiang Yuan
Journal:  Front Pharmacol       Date:  2021-05-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.